It has been found that the specific syrup of coughing, the codrif, contains diethylene glycol (DEG) beyond the permissible limit, in the investigation of the death of nine children from the kidney failure in the district of Chhindware in Madhya Pradesh, the Ministry of Health presented on Saturday.
Before the day, the government stated that the tests for samples of coughing coughs from Madhya Pradesh did not show any contamination by toxic substances.
The new finding focuses back on pharmaceutical contamination as the cause of death.
The discovery was carried out after Tamil’s Food and Drug Administration (FDA) gathered and tested samples of syrup cough from the production premises of M/S Sresan Pharma in Kanchipuram at the request of Madhya Pradesh.
Also read | Mint Explanation How cheap unhealthy food promotes childhood obesity
The government said the results, shared late evening 3. October, confirmed the presence of DEG, a toxic substance known to cause serious kidney damage.
Nine children died in Madhya Pradesh and two in Rajasthan of acute kidney failure in the last two weeks.
Nationwide counseling
Meanwhile, the CEO of the Health Services (DGHS) at the Ministry of Health and Family Care has issued nationwide advice on the rational use of cough syrups in the pediatric population.
Advice states that in constant efforts to ensure rational use of drugs and patients’ safety repeats reasonable prescription and issuance of cough syrups for children.
He noted that most acute cough diseases in children are “restrictive” and are often reflected without pharmacological intervention.
DGHS advises that cough and cold medicines should not be prescribed or issued to children under the age of two.
Also read | Forget the webmd, can you believe AI with monitoring your health?
“These are generally not recommended for ages for ages, and for the above, any use should adhere to careful clinical evaluation with close supervision and strict adherence to the appropriate dosage, the shortest effective duration and avoiding multiple drug combinations.”
Advice also recommends that the public be sensitized to compliance with regulations.
In response to this critical development, the government launched a “risk -based” inspection in the production premises of all 19 drugs that have been sampled, extended across six states.
The aim of this event, which launched October 3, is to identify gaps that led to this failure of quality and propose improvements to avoid these incidents in the future.
Revelation comes in the middle of a wider investigation into the cause of children’s death. While the initial probe did not find any contamination in the cough syrup, it spread to include the environmental factors after one case was found positive to leptospirosis, bacterial diseases caused by exposure to water or soil.
Also read | Indian boom Healthy food: Why are refreshments rich in protein in every basket
The multidisciplinary team, consisting of experts from Virology National Institute (NIVE), Indian Council of Medical Research (ICMR), Neeri, Standard Drug Control (CDSCO) and AIims Nagpur, continues to analyze various samples and factors to assess the cause of death in Chhindware.
This tragic incident also serves as a grim reminder of similar crises that previously stained an Indian pharmaceutical reputation.
In 2022, the World Health Organization issued alerts after the cough syrups in the cough Indian were associated with the death of children in Gambia and Uzbekistan, while the tests confirm the presence of fatal contaminants.
(tagstotranslate) Coldrif Cough Syrup
